 | • レポートコード：D0GIR-01049 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血液脳関門薬物デリバリーの世界市場を広く調査・分析し、今後の市場展望をまとめております。血液脳関門薬物デリバリーの種類別市場規模（トロイ木馬アプローチ、二重特異性抗体RMTアプローチ、透過性向上、その他）、用途別市場規模（アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Ossianix、Roche、ArmaGen Technologies、Insightec、CarThera、AngioChem、Bioasis Technologies Inc.、BrainsGate、Iproteos S.L. ・地域別グローバル市場分析 2015年-2020年 ・血液脳関門薬物デリバリーの北米市場（アメリカ、カナダ、メキシコ） ・血液脳関門薬物デリバリーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・血液脳関門薬物デリバリーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・血液脳関門薬物デリバリーの南米市場（ブラジル、アルゼンチン） ・血液脳関門薬物デリバリーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：トロイ木馬アプローチ、二重特異性抗体RMTアプローチ、透過性向上、その他 ・用途別分析：アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Drug Delivery Across Blood Brain Barrier market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Drug Delivery Across Blood Brain Barrier sales will be xx in 2020 from Drug Delivery Across Blood Brain Barrier million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Drug Delivery Across Blood Brain Barrier market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Drug Delivery Across Blood Brain Barrier industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Drug Delivery Across Blood Brain Barrier and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Drug Delivery Across Blood Brain Barrier market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drug Delivery Across Blood Brain Barrier market has been segmented into:
Trojan Horse Approach
Bispecific Antibody RMT Approach
Increasing Permeability
Others
By Application, Drug Delivery Across Blood Brain Barrier has been segmented into:
Alzheimer’s
Epilepsy
Parkinson’s
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug Delivery Across Blood Brain Barrier market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug Delivery Across Blood Brain Barrier markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug Delivery Across Blood Brain Barrier market.
The report offers in-depth assessment of the growth and other aspects of the Drug Delivery Across Blood Brain Barrier market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Drug Delivery Across Blood Brain Barrier Market Share Analysis
Drug Delivery Across Blood Brain Barrier competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drug Delivery Across Blood Brain Barrier sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug Delivery Across Blood Brain Barrier sales, revenue and market share for each player covered in this report.
The major players covered in Drug Delivery Across Blood Brain Barrier are:
Ossianix
Roche
ArmaGen Technologies
Insightec
CarThera
AngioChem
Bioasis Technologies Inc.
BrainsGate
Iproteos S.L.
Among other players domestic and global, Drug Delivery Across Blood Brain Barrier market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Drug Delivery Across Blood Brain Barrier Market Overview
1.1 Product Overview and Scope of Drug Delivery Across Blood Brain Barrier
1.2 Classification of Drug Delivery Across Blood Brain Barrier by Technology
1.2.1 Global Drug Delivery Across Blood Brain Barrier Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drug Delivery Across Blood Brain Barrier Revenue Market Share by Technology in 2019
1.2.3 Trojan Horse Approach
1.2.4 Bispecific Antibody RMT Approach
1.2.5 Increasing Permeability
1.2.6 Others
1.3 Global Drug Delivery Across Blood Brain Barrier Market by Application
1.3.1 Overview: Global Drug Delivery Across Blood Brain Barrier Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Alzheimer’s
1.3.3 Epilepsy
1.3.4 Parkinson’s
1.3.5 Multiple Sclerosis
1.3.6 Hunter’s Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Global Drug Delivery Across Blood Brain Barrier Market by Regions
1.4.1 Global Drug Delivery Across Blood Brain Barrier Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drug Delivery Across Blood Brain Barrier (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drug Delivery Across Blood Brain Barrier Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drug Delivery Across Blood Brain Barrier Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Delivery Across Blood Brain Barrier Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drug Delivery Across Blood Brain Barrier Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Delivery Across Blood Brain Barrier Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Drug Delivery Across Blood Brain Barrier Industry Impact
1.5.1 COVID-19 Potential Implications for the Drug Delivery Across Blood Brain Barrier
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Drug Delivery Across Blood Brain Barrier
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Ossianix
2.1.1 Ossianix Details
2.1.2 Ossianix Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ossianix SWOT Analysis
2.1.4 Ossianix Product and Services
2.1.5 Ossianix Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.3 ArmaGen Technologies
2.3.1 ArmaGen Technologies Details
2.3.2 ArmaGen Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ArmaGen Technologies SWOT Analysis
2.3.4 ArmaGen Technologies Product and Services
2.3.5 ArmaGen Technologies Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.4 Insightec
2.4.1 Insightec Details
2.4.2 Insightec Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Insightec SWOT Analysis
2.4.4 Insightec Product and Services
2.4.5 Insightec Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.5 CarThera
2.5.1 CarThera Details
2.5.2 CarThera Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CarThera SWOT Analysis
2.5.4 CarThera Product and Services
2.5.5 CarThera Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.6 AngioChem
2.6.1 AngioChem Details
2.6.2 AngioChem Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AngioChem SWOT Analysis
2.6.4 AngioChem Product and Services
2.6.5 AngioChem Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bioasis Technologies Inc.
2.7.1 Bioasis Technologies Inc. Details
2.7.2 Bioasis Technologies Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bioasis Technologies Inc. SWOT Analysis
2.7.4 Bioasis Technologies Inc. Product and Services
2.7.5 Bioasis Technologies Inc. Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.8 BrainsGate
2.8.1 BrainsGate Details
2.8.2 BrainsGate Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BrainsGate SWOT Analysis
2.8.4 BrainsGate Product and Services
2.8.5 BrainsGate Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
2.9 Iproteos S.L.
2.9.1 Iproteos S.L. Details
2.9.2 Iproteos S.L. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Iproteos S.L. SWOT Analysis
2.9.4 Iproteos S.L. Product and Services
2.9.5 Iproteos S.L. Drug Delivery Across Blood Brain Barrier Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drug Delivery Across Blood Brain Barrier Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug Delivery Across Blood Brain Barrier Players Market Share
3.2.2 Top 10 Drug Delivery Across Blood Brain Barrier Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drug Delivery Across Blood Brain Barrier Revenue and Market Share by Regions
4.2 North America Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
4.3 Europe Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
4.5 South America Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
5 North America Drug Delivery Across Blood Brain Barrier Revenue by Countries
5.1 North America Drug Delivery Across Blood Brain Barrier Revenue by Countries (2015-2020)
5.2 USA Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
5.3 Canada Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
5.4 Mexico Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
6 Europe Drug Delivery Across Blood Brain Barrier Revenue by Countries
6.1 Europe Drug Delivery Across Blood Brain Barrier Revenue by Countries (2015-2020)
6.2 Germany Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
6.3 UK Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
6.4 France Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
6.5 Russia Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
6.6 Italy Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue by Countries
7.1 Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue by Countries (2015-2020)
7.2 China Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
7.3 Japan Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
7.4 Korea Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
7.5 India Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
8 South America Drug Delivery Across Blood Brain Barrier Revenue by Countries
8.1 South America Drug Delivery Across Blood Brain Barrier Revenue by Countries (2015-2020)
8.2 Brazil Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
8.3 Argentina Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Drug Delivery Across Blood Brain Barrier by Countries
9.1 Middle East & Africa Drug Delivery Across Blood Brain Barrier Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
9.3 UAE Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
9.4 Egypt Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
9.5 South Africa Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drug Delivery Across Blood Brain Barrier Revenue and Market Share by Technology (2015-2020)
10.2 Global Drug Delivery Across Blood Brain Barrier Market Forecast by Technology (2019-2024)
10.3 Trojan Horse Approach Revenue Growth Rate (2015-2025)
10.4 Bispecific Antibody RMT Approach Revenue Growth Rate (2015-2025)
10.5 Increasing Permeability Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Drug Delivery Across Blood Brain Barrier Market Segment by Application
11.1 Global Drug Delivery Across Blood Brain Barrier Revenue Market Share by Application (2015-2020)
11.2 Drug Delivery Across Blood Brain Barrier Market Forecast by Application (2019-2024)
11.3 Alzheimer’s Revenue Growth (2015-2020)
11.4 Epilepsy Revenue Growth (2015-2020)
11.5 Parkinson’s Revenue Growth (2015-2020)
11.6 Multiple Sclerosis Revenue Growth (2015-2020)
11.7 Hunter’s Syndrome Revenue Growth (2015-2020)
11.8 Brain Cancer Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global Drug Delivery Across Blood Brain Barrier Market Size Forecast (2021-2025)
12.1 Global Drug Delivery Across Blood Brain Barrier Market Size Forecast (2021-2025)
12.2 Global Drug Delivery Across Blood Brain Barrier Market Forecast by Regions (2021-2025)
12.3 North America Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
12.4 Europe Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
12.6 South America Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Drug Delivery Across Blood Brain Barrier Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drug Delivery Across Blood Brain Barrier by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drug Delivery Across Blood Brain Barrier Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drug Delivery Across Blood Brain Barrier Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Drug Delivery Across Blood Brain Barrier Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Ossianix Corporate Information, Location and Competitors
Table 7. Ossianix Drug Delivery Across Blood Brain Barrier Major Business
Table 8. Ossianix Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 9. Ossianix SWOT Analysis
Table 10. Ossianix Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 11. Ossianix Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Roche Corporate Information, Location and Competitors
Table 13. Roche Drug Delivery Across Blood Brain Barrier Major Business
Table 14. Roche Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2018-2019)
Table 15. Roche SWOT Analysis
Table 16. Roche Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 17. Roche Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. ArmaGen Technologies Corporate Information, Location and Competitors
Table 19. ArmaGen Technologies Drug Delivery Across Blood Brain Barrier Major Business
Table 20. ArmaGen Technologies Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 21. ArmaGen Technologies SWOT Analysis
Table 22. ArmaGen Technologies Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 23. ArmaGen Technologies Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Insightec Corporate Information, Location and Competitors
Table 25. Insightec Drug Delivery Across Blood Brain Barrier Major Business
Table 26. Insightec Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 27. Insightec SWOT Analysis
Table 28. Insightec Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 29. Insightec Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. CarThera Corporate Information, Location and Competitors
Table 31. CarThera Drug Delivery Across Blood Brain Barrier Major Business
Table 32. CarThera Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 33. CarThera SWOT Analysis
Table 34. CarThera Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 35. CarThera Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. AngioChem Corporate Information, Location and Competitors
Table 37. AngioChem Drug Delivery Across Blood Brain Barrier Major Business
Table 38. AngioChem Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 39. AngioChem SWOT Analysis
Table 40. AngioChem Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 41. AngioChem Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Bioasis Technologies Inc. Corporate Information, Location and Competitors
Table 43. Bioasis Technologies Inc. Drug Delivery Across Blood Brain Barrier Major Business
Table 44. Bioasis Technologies Inc. Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 45. Bioasis Technologies Inc. SWOT Analysis
Table 46. Bioasis Technologies Inc. Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 47. Bioasis Technologies Inc. Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. BrainsGate Corporate Information, Location and Competitors
Table 49. BrainsGate Drug Delivery Across Blood Brain Barrier Major Business
Table 50. BrainsGate Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 51. BrainsGate SWOT Analysis
Table 52. BrainsGate Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 53. BrainsGate Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Iproteos S.L. Corporate Information, Location and Competitors
Table 55. Iproteos S.L. Drug Delivery Across Blood Brain Barrier Major Business
Table 56. Iproteos S.L. Drug Delivery Across Blood Brain Barrier Total Revenue (USD Million) (2017-2018)
Table 57. Iproteos S.L. SWOT Analysis
Table 58. Iproteos S.L. Drug Delivery Across Blood Brain Barrier Product and Solutions
Table 59. Iproteos S.L. Drug Delivery Across Blood Brain Barrier Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) by Players (2015-2020)
Table 61. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Players (2015-2020)
Table 62. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Drug Delivery Across Blood Brain Barrier Revenue Market Share by Regions (2015-2020)
Table 64. North America Drug Delivery Across Blood Brain Barrier Revenue by Countries (2015-2020)
Table 65. North America Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Table 66. Europe Drug Delivery Across Blood Brain Barrier Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Drug Delivery Across Blood Brain Barrier Revenue by Countries (2015-2020)
Table 69. South America Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Drug Delivery Across Blood Brain Barrier Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Table 72. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) by Type (2015-2020)
Table 73. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Type (2015-2020)
Table 74. Global Drug Delivery Across Blood Brain Barrier Revenue Forecast by Type (2021-2025)
Table 75. Global Drug Delivery Across Blood Brain Barrier Revenue by Application (2015-2020)
Table 76. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Application (2015-2020)
Table 77. Global Drug Delivery Across Blood Brain Barrier Revenue Forecast by Application (2021-2025)
Table 78. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drug Delivery Across Blood Brain Barrier Picture
Figure 2. Global Drug Delivery Across Blood Brain Barrier Revenue Market Share by Technology in 2019
Figure 3. Trojan Horse Approach Picture
Figure 4. Bispecific Antibody RMT Approach Picture
Figure 5. Increasing Permeability Picture
Figure 6. Others Picture
Figure 7. Drug Delivery Across Blood Brain Barrier Revenue Market Share by Application in 2019
Figure 8. Alzheimer’s Picture
Figure 9. Epilepsy Picture
Figure 10. Parkinson’s Picture
Figure 11. Multiple Sclerosis Picture
Figure 12. Hunter’s Syndrome Picture
Figure 13. Brain Cancer Picture
Figure 14. Others Picture
Figure 15. Global Drug Delivery Across Blood Brain Barrier Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Drug Delivery Across Blood Brain Barrier Revenue Market Share in 2019
Figure 24. Global Top 10 Players Drug Delivery Across Blood Brain Barrier Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Drug Delivery Across Blood Brain Barrier Revenue Market Share by Regions (2015-2020)
Figure 28. Global Drug Delivery Across Blood Brain Barrier Revenue Market Share by Regions in 2018
Figure 29. North America Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 30. Europe Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 32. South America Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 34. North America Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Figure 35. North America Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries in 2019
Figure 36. USA Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 37. Canada Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 39. Europe Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries in 2019
Figure 41. Germany Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 42. UK Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 43. France Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 44. Russia Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 45. Italy Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries in 2019
Figure 48. China Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 49. Japan Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 50. Korea Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 51. India Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 53. South America Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Figure 54. South America Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries in 2019
Figure 55. Brazil Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Drug Delivery Across Blood Brain Barrier Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 60. UAE Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Drug Delivery Across Blood Brain Barrier Revenue and Growth Rate (2015-2020)
Figure 63. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Type (2015-2020)
Figure 64. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Type in 2019
Figure 65. Global Drug Delivery Across Blood Brain Barrier Market Share Forecast by Type (2021-2025)
Figure 66. Global Trojan Horse Approach Revenue Growth Rate (2015-2020)
Figure 67. Global Bispecific Antibody RMT Approach Revenue Growth Rate (2015-2020)
Figure 68. Global Increasing Permeability Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Application (2015-2020)
Figure 71. Global Drug Delivery Across Blood Brain Barrier Revenue Share by Application in 2019
Figure 72. Global Drug Delivery Across Blood Brain Barrier Market Share Forecast by Application (2021-2025)
Figure 73. Global Alzheimer’s Revenue Growth Rate (2015-2020)
Figure 74. Global Epilepsy Revenue Growth Rate (2015-2020)
Figure 75. Global Parkinson’s Revenue Growth Rate (2015-2020)
Figure 76. Global Multiple Sclerosis Revenue Growth Rate (2015-2020)
Figure 77. Global Hunter’s Syndrome Revenue Growth Rate (2015-2020)
Figure 78. Global Brain Cancer Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Drug Delivery Across Blood Brain Barrier Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Drug Delivery Across Blood Brain Barrier Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
Figure 84. Europe Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
Figure 86. South America Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Drug Delivery Across Blood Brain Barrier Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
鎮痛剤デリバリーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pain Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pain Drug Delivery market …- ナノテクノロジードラッグデリバリーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Nanotechnology Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 8000.6 million by 2025, from USD 6153.4 million in 2019. The Nanotec…
- 非侵襲性ドラッグデリバリーデバイスの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Non-Invasive Drug Delivery Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 放出制御ドラッグデリバリーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Controlled Release Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.6% in the forecast period of 2020 to 2025 and will expected to reach USD 59690 million by 2025, from USD 44540 million in 2019. The Contr…
- 注射型ドラッグデリバリー機器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drug Delivery Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …